The nation of Zimbabwe has declined a major US health deal valued at $367m (272 million pounds) over five years because of Washington's request for sensitive data.
This rejection became public following a government memo from December was disclosed, indicating that President Emmerson Mnangagwa believed the arrangement was "skewed".
An official spokesperson has since stated that the US was seeking biological samples for research and profit while was unwilling to guarantee the resulting advantages from any future medical innovations.
"We are forced to start the challenging and unfortunate task of ending our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had donated more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has called for more talks to reach a agreement acceptable to all parties so the country's critical HIV programme can be sustained.
Wider Implications
This development follows a similar case in Kenya, where a high court blocked a similar deal with the US following legal challenges were filed about the safety of citizens' medical information.
After returning to office recently, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
USAID had administered aid for the US government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to boost openness and responsibility.
According to reports, 16 African countries have to date signed similar agreements, constituting over $18.3bn in new funding.
Specifics of the Declined Deal
The funds for Zimbabwe was intended to supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this partnership might have yielded significant benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on antiretroviral therapy via American-funded programmes," Tremont commented.
However, official spokesman Nick Mangwana argued the arrangement was "unequal".
"Our nation was requested to surrender its genetic material and health information indefinitely, without any corresponding assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.
"In essence, our nation would supply the raw materials for scientific discovery without any certainty that the end products would be accessible to our citizens should a future pandemic emerge."
Sovereignty and Global Health
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were upending systems already set up through the international organization.
The spokesperson cited its Pathogen Access and Benefit Sharing framework created to deal with potential pandemics.
"This framework is intended to ensure that when a country contributes its information, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the funds to create them."
Zimbabwe's reservations over the US deal "must not be interpreted as hostility towards the US," he added.
"We encourage continued discussions with our US partners on how future collaboration might be structured in a way that honours the independence and dignity of each country."
Medical Community Response
A leading public health body said it acknowledged the government's concerns, but recommended that negotiations should continue since a large portion of the nation's Aids initiatives depended on international support.
"In cases where technical issues arise, including those involving data governance or implementation frameworks, these can often be resolved through detailed discussion and negotiated safeguards," the group commented.
This impasse highlights the ongoing tensions between accepting much-needed foreign assistance and safeguarding a country's data in an increasingly interconnected world.